The Ohio Pharmacists Foundation (OPF) was created in 1992 to meet the educational needs of pharmacists and to provide an avenue to study and provide new and unique health care services to the public by the pharmacist. As such, the OPF provides educational training programs and supports the conduct of practice oriented research that demonstrates the value of the pharmacist in enhancing the delivery of pharmacy care and the attainment of optimal patient outcomes. The OPF Research Grant Program is the venue through which the OPF partners with investigators at colleges of pharmacy, health care institutions and health-oriented industries to discover innovative roles, and overcome barriers, for the pharmacist to deliver health care.
Note: An individual interested in submitting a proposal for support through the OPF Research Grant Program should contact Kathy Nameth, Director of Continuing Education for the Ohio Pharmacists Association, to ensure the intended submission is in compliance with the program's purposes and guidelines.
The proposal will be evaluated by the members of the OPF Board of Trustees using established criteria in each of the key areas identified above. Additionally, the proposal will be judged on the adequacy and justification of budget as well as additional support sought for the project (including "in kind" contributions). Organization, neatness and grammatical correctness of the text also will be scored.
All research involving human subjects and/or health related records must be reviewed and approved by the human subjects' research review committee (or equivalent IRB) of the institution with which the investigator is affiliated. The OPA/OPF does not provide this research assurance. If a study is exempt from research review, that fact must be affirmatively stated in the proposal and cover letter.
A letter of support from the appropriate academic advisor, program director, supervisor or administrator must be secured and submitted with the application. Further, any proposal describing a study done in cooperation with an entity other than one directly affiliated with the investigator(s), must be accompanied by a letter of support from the appropriate authority at that agency.
No action will be taken on the proposal until these assurances are received
An investigator who is successful in securing funding from the OPF shall conduct the study and expend the funds in the same manner as described in the project proposal. Any significant deviations from the submitted protocol and/or timeline should be communicated in a prompt manner to the OPF President (at the address above).
When the project is completed, a report of the project findings shall be submitted to the OPF President. The project report must be submitted in an electronic format and include all relevant study parameters, findings and conclusions. The report may be published in part or in whole in the OPA journal, Ohio Pharmacist, and shall be presented at the OPA Annual Conference immediately following completion of the project.
All funds awarded by OPF through this program will be sent to an institutional account where the investigator is employed/affiliated. No funds will be awarded directly to any individual.
Proposals will be evaluated twice annually at scheduled meetings of the OPF Board of Trustees. As such, submission deadline dates are:
The Ohio Pharmacists Foundation, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. "The ACPE Provider Accreditation Program is designed to assure pharmacists, boards of pharmacy, and other members of pharmacy's community of interests, of the quality of continuing pharmaceutical education programs. Quality is assured by evaluating and monitoring capabilities of providers of continuing education programs as well as monitoring and reviewing their continuing education offerings."
As an accredited provider, OPF must adhere to the Criteria for Quality established by ACPE and provide periodic self-assessment reports for review in order to maintain approved-provider status.